MSc MSc - Faron Pharmaceuticals Interim Officer

FARN Stock   165.00  10.00  5.71%   

Executive

MSc MSc is Interim Officer of Faron Pharmaceuticals Oy
Age 66
Address Joukahaisenkatu 6 B, Turku, Finland, 20520
Phone358 2469 5151
Webhttps://www.faron.com

Faron Pharmaceuticals Management Efficiency

The company has return on total asset (ROA) of (0.7) % which means that it has lost $0.7 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (39.615) %, meaning that it generated substantial loss on money invested by shareholders. Faron Pharmaceuticals' management efficiency ratios could be used to measure how well Faron Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Faron Pharmaceuticals' Total Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 2.5 M in 2024, whereas Intangible Assets are likely to drop slightly above 691.5 K in 2024.

Similar Executives

Showing other executives

EXECUTIVE Age

Deanna JonesBaker Hughes Co
55
Gregory LusardiONEOK Inc
N/A
Georgia MagnoBaker Hughes Co
45
Daniel BriggsLas Vegas Sands
N/A
Gavin FelderYum Brands
44
James ApostolidesBaker Hughes Co
45
Nancy CPABaker Hughes Co
54
Steve AngeloToyota Motor Corp
69
Keiji YamamotoToyota Motor Corp
63
David SylvesterLas Vegas Sands
60
Chase MulvehillBaker Hughes Co
N/A
Laszlo BencsikOTP Bank Nyrt
54
Toshiaki TaguchiToyota Motor Corp
73
Darren WallisONEOK Inc
N/A
Thomas MarecicAmetek Inc
62
Ralph IzzoPublic Service Enterprise
66
Sheila RostiacPublic Service Enterprise
53
Bradley FeldSoftBank Group Corp
57
James FrippYum Brands
N/A
David JointFreeport McMoRan
N/A
Robert TownsendSoftBank Group Corp
68
Faron Pharmaceuticals Oy (FARN) is traded on London Exchange in UK and employs 34 people. Faron Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Faron Pharmaceuticals Leadership Team

Elected by the shareholders, the Faron Pharmaceuticals' board of directors comprises two types of representatives: Faron Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Faron. The board's role is to monitor Faron Pharmaceuticals' management team and ensure that shareholders' interests are well served. Faron Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Faron Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Juhana Heinonen, Chief Officer
Birge MD, Interim Officer
Markku Jalkanen, Founder Director
Vesa LLM, General Counsel
MD MSc, Chief Officer
Jennifer SmithParker, Head Communications
Maija Hollmen, Chief Officer
Petri MD, Chief Officer
MSc MSc, Interim Officer

Faron Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Faron Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Faron Stock Analysis

When running Faron Pharmaceuticals' price analysis, check to measure Faron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Faron Pharmaceuticals is operating at the current time. Most of Faron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Faron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Faron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Faron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.